Local Group Raises Money For Multiple Myeloma Research

September 30, 2010

COLUMBUS, Ohio – In only three short years, a local fundraising organization started by a single family has raised more than $300,000 for multiple myeloma research at The Ohio State University Comprehensive Cancer Center- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).

MMORE, which stands for Multiple Myeloma Opportunities for Research and Education, was founded by Nancy Kaufmann and Steve Fink of Upper Arlington in 2008 to honor their daughter, Sarah Kaufmann-Fink, who was diagnosed with the rare and incurable blood cancer at the age of 22. Sarah, now 27, is in remission after a treatment regimen that included chemotherapy, radiation and a stem-cell transplant.

Fundraisers this year included the CelebrateMMORE gala in February and the MoveMMORE 5K race and 1-mile fun run in September.

Another fundraising group – Coaches Against Multiple Myeloma – donated more than $27,000 to MMORE that they raised during a youth baseball tournament held in May at Berliner Park that attracted more than 120 teams from around the state. Multiple myeloma survivor and OSUCCC-James patient Matt Hare, 26, of New Albany, organized the baseball tournament with the help of his father, Doug Hare of Pataskala.

In addition, Matt Hare joined the 44-member RideMMORE Peloton that raised more than $50,000 in Pelotonia, a grassroots bicycle tour held each August that raises money for cancer research at OSUCCC-James.

“As a result of these fundraising efforts, we are more quickly able to translate bench to bedside research, allowing us to start clinical trials with multiple myeloma patients much sooner,” said Dr. Don Benson, a hematologist and oncologists who specializes in researching and treating multiple myeloma at OSUCCC-James.

About 60,000 people in the United States have multiple myeloma, and more than 20,000 new cases are diagnosed annually. The average survival from diagnosis is less than 10 years.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (cancer.osu.edu) is one of only 40 Comprehensive Cancer Centers in the United States designated by the National Cancer Institute. Ranked by U.S. News & World Report among the top cancer hospitals in the nation, The James is the 180-bed adult patient-care component of the cancer program at The Ohio State University. The OSUCCC-James is one of only seven funded programs in the country approved by the NCI to conduct both Phase I and Phase II clinical trials.

# # #

Related Links:

  • Click here for a high-quality photo of the Hare and Kaufmann families. From left to right, Steve Fink and Nancy Kaufmann of MMORE, Kate McGuinness, fiancée of multiple myeloma survivor and fundraise Matt Hare, and his parents Rhonda and Doug Hare.

Eileen Scahill
Medical Center Public Affairs and Media Relations
614-293-3737
Eileen.Scahill@osumc.edu

Contact Media Staff

Amanda Harper

Director of Media Relations


614-685-5420 (direct)


614-293-3737 (main)


Amanda.Harper2@osumc.edu


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.

 

If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).

Latest News

Immune-Boosting Research Holds Promise for Multiple Myeloma Patients

Experts at The James are harnessing the power of the body’s own immune system to attack cancer for multiple myeloma patients.

Chitosan-Coated, Chemotherapy-Packed Nanoparticles May Target Cancer Stem Cells

Nanoparticles packed with a clinically used chemotherapy drug and coated with an oligosaccharide derived from the carapace of crustaceans might effectively target and kill cancer stem-like cells...

Pelotonia 2015 – Getting Us Even Closer to a Cancer-Free World

Mile by mile, Pelotonia riders, virtual riders and thousands of volunteers are helping us get even closer to a cancer-free world, and every single dollar raised goes directly to cancer research at the...